Strata Critical MedicalSRTA -1.21%71 Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates SRTA with a GF Score™ of 71/100 and a GF Value™ of $4.47 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Strata Critical Medical ranks worse than 363636% on this metric.
As of today (2026-06-26), the Forward Annual Dividend Yield of Strata Critical Medical is 0.00%.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Strata Critical Medical is 0.00%.
SRTA's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.48 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Strata Critical Medical (NAS:SRTA) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Strata Critical Medical Forward Dividend Yield % Related Terms
SRTA vs TOI, GMRS, CCRN: Forward Dividend Yield % Comparison
For the Medical Care Facilities subindustry, Strata Critical Medical's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Strata Critical Medical (SRTA) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Strata Critical Medical and its competitors. According to the industry distribution chart, Strata Critical Medical ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Strata Critical Medical's Forward Dividend Yield % too high?
Strata Critical Medical's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Strata Critical Medical ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Strata Critical Medical has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's Forward Dividend Yield % compare to TOI and GMRS?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #999999 out of 275 companies for Forward Dividend Yield %. This places Strata Critical Medical in the lower half of its industry. The industry median Forward Dividend Yield % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.48, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Strata Critical Medical and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.47, compared to a current price of $5.30 — trading 18.5% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Strata Critical Medical's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Critical Medical (SRTA) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued.
The current stock price of $5.30 is trading 18.5% above its estimated GF Value™ of $4.47.
GuruFocus considers Strata Critical Medical to be Modestly Overvalued.
Key valuation signals for SRTA:
Forward Dividend Yield %: 0.00%
GF Value™: $4.47 vs. price of $5.30 (18.5% above fair value)
No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
71GF Score
Get the complete analysis for SRTA
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTA has been successfully added to your 